Article
The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.
American journal of physiology. Gastrointestinal and liver physiology - 1 Nov 2010
Lin Songbai, Lee Sei-Jung, Shim Hyunsuk, Chun Jerold, Yun C Chris
Abstract excerpt
Lysophosphatidic acid (LPA) is a lipid mediator that mediates several effects that promote cancer progress. The LPA receptor type 2 (LPA(2)) expression is often elevated in several types of cancers, including colorectal cancer (CRC). In this study, we investigated the role of LPA(2) in the develo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
